Your browser doesn't support javascript.
loading
Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
de Leon, Jose; Schoretsanitis, Georgios; Smith, Robert L; Molden, Espen; Solismaa, Anssi; Seppälä, Niko; Kopecek, Miloslav; Svancer, Patrik; Olmos, Ismael; Ricciardi, Carina; Iglesias-Garcia, Celso; Iglesias-Alonso, Ana; Spina, Edoardo; Ruan, Can-Jun; Wang, Chuan-Yue; Wang, Gang; Tang, Yi-Lang; Lin, Shih-Ku; Lane, Hsien-Yuan; Kim, Yong Sik; Kim, Se Hyun; Rajkumar, Anto P; González-Esquivel, Dinora F; Jung-Cook, Helgi; Baptista, Trino; Rohde, Christopher; Nielsen, Jimmi; Verdoux, Hélène; Quiles, Clelia; Sanz, Emilio J; De Las Cuevas, Carlos; Cohen, Dan; Schulte, Peter F J; Ertugrul, Aygün; Anil Yagcioglu, A Elif; Chopra, Nitin; McCollum, Betsy; Shelton, Charles; Cotes, Robert O; Kaithi, Arun R; Kane, John M; Farooq, Saeed; Ng, Chee H; Bilbily, John; Hiemke, Christoph; López-Jaramillo, Carlos; McGrane, Ian; Lana, Fernando; Eap, Chin B; Arrojo-Romero, Manuel.
  • de Leon J; Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA.
  • Schoretsanitis G; Department of Psychiatry, University of Kentucky, Lexington, KY, USA.
  • Smith RL; Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain.
  • Molden E; Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apostol Hospital, University of the Basque Country, Vitoria, Spain.
  • Solismaa A; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland.
  • Seppälä N; The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA.
  • Kopecek M; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
  • Svancer P; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
  • Olmos I; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.
  • Ricciardi C; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Iglesias-Garcia C; Department of Psychiatry, Tampere University Hospital, Tampere, Finland.
  • Iglesias-Alonso A; Department of Psychiatry, Satasairaala, Finland.
  • Spina E; National Institute of Mental Health, Klecany, Czech Republic.
  • Ruan CJ; Department of Psychiatry, Charles University, Third Faculty of Medicine, Prague, Czech Republic.
  • Wang CY; National Institute of Mental Health, Klecany, Czech Republic.
  • Wang G; Department of Psychiatry, Charles University, Third Faculty of Medicine, Prague, Czech Republic.
  • Tang YL; Clinical Pharmacology Unit and Pharmacy Department, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay.
  • Lin SK; Clinical Pharmacology Unit and Outpatient Clinic, Vilardebó Hospital, Administración de Servicios de Salud, Montevideo, Uruguay.
  • Lane HY; Universidad de Oviedo. CIBERSAM. INEUROPA. ISPA-FIMBA, Oviedo, Spain.
  • Kim YS; Hospital Valle del Nalón, Langreo, Spain.
  • Kim SH; Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Rajkumar AP; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • González-Esquivel DF; Laboratory of Clinical Psychopharmacology, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • Jung-Cook H; The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • Baptista T; The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • Rohde C; Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • Nielsen J; The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
  • Verdoux H; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Quiles C; Substance Abuse Treatment Program, Atlanta VA Medical Center, Decatur, Georgia, USA.
  • Sanz EJ; Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • De Las Cuevas C; Department of Psychiatry, School of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Cohen D; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
  • Schulte PFJ; Department of Psychiatry and Brain Disease Research Center, China Medical University Hospital, Taichung, Taiwan.
  • Ertugrul A; Department of Psychology, College of Medical and Health Sciences, Asia University, Taichung, Taiwan.
  • Anil Yagcioglu AE; Department of Neuropsychiatry, Nowon Eulji Medical Center, Eulji University, School of Medicine, Seoul, Korea.
  • Chopra N; Department of Psychiatry, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • McCollum B; Department of Psychiatry, Christian Medical College, Vellore, India.
  • Shelton C; Institute of Mental Health, Jubilee Campus, University of Nottingham, Triumph Road, Nottingham, United Kingdom.
  • Cotes RO; Instituto Nacional de Neurología y Neurocirugía, México City, México.
  • Kaithi AR; Instituto Nacional de Neurología y Neurocirugía, México City, México.
  • Kane JM; Facultad de Química, Universidad Nacional Autónoma de México (UNAM), México City, México.
  • Farooq S; Department of Physiology, Los Andes University Medical School, Mérida, Venezuela.
  • Ng CH; Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
  • Bilbily J; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Hiemke C; Mental Health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark.
  • López-Jaramillo C; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France.
  • McGrane I; Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, F-33000 Bordeaux, France.
  • Lana F; Department of Physical Medicine and Pharmacology, School of Medicine, Universidad de La Laguna, Canary Islands, Spain.
  • Eap CB; Hospital Universitario de Canarias, Tenerife, Spain.
  • Arrojo-Romero M; Department of Internal Medicine, Dermatology and Psychiatry, School of Medicine, and Instituto Universitario de Neurociencia (IUNE), University of La Laguna, Canary Islands, Spain.
Pharmacopsychiatry ; 55(2): e1, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35052001

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Año: 2022 Tipo del documento: Article